🦊/Investors

Oxford Finance LLC

Venture debt

Alexandria · Seed–Late Stage · 45 people tracked

Find your way into Oxford Finance LLC

451 people in our graph share verified history with the Oxford Finance LLC team — schools, employers, funds. One of them is your warm intro.

Ottounlockedknows Tracy Maziek · together at Siemens Financial Services (overlapped)
×7knows the team · via Wells Fargo Capital Finance
×3knows the team · via Grant Thornton, LLP
knows the team · via Virginia Tech - Pamplin College of Business
Fox Verdict
Sign up to see your fit

Investment thesis

Oxford Finance's real estate team focuses on facility-based healthcare lending across acute, post-acute, and specialty segments in the United States. It offers financing for working capital, acquisitions, refinancing, cash-out recaps, and property transitions, serving both operators and investor-owners of single assets or portfolios. Products include working capital revolvers, senior term loans, Term Loan B and second lien, mezzanine loans, and equity or structured equity, backed by full capital markets capability. Loan sizes range from $5MM to $125MM with tenors up to five years, initial interest-only periods, and amortization up to 25 years.

Source: firm website, verified Sep 15, 2026.

Stage
Seed–Late Stage
Check
$5M – $125M
HQ
Alexandria, Virginia, US
Instruments
Debt
Founded
2002
AUM
$2.4B
Tracked investments
9
IPOs
1

Team · 45 people

from the firm's website & public directories
J. Alden Philbrick, IV· Executive Chairman & Founder
J. Alden Philbrick· IV, Executive Chairman and Founderin
Ajay Nanda· Managing Director
Kevin Harbour· Managing Director
Mark Hirsh· Managing Directorin
Nick McDearis· Managing Directorin
Peter Dahms· Managing Director
Phil Tonucci· Managing Director
Richard Russakoff· Managing Director
Sunil Annapareddy· Managing Directorin
David Hickman· Managing Director, Co-Head of Enterprise Lendingin
Garrett Henn· Managing Director, Co-Head of Enterprise Lending
Joseph Somerset· Managing Director, Portfolio Management
Austin Szafranski· Executive Director
Charles Boyle· Senior Directorin
Dorin Fachiol· Senior Directorin
Eric Schwartz· Executive Directorin
Eric Veale· Senior Directorin
Kevin Smith· Senior Directorin
Krister Anderson· Senior Director, Portfolio Management
Patrick McLenahan· Executive Director, Portfolio Managementin
Amanda Stern· Director of Marketingin
Desirée Williams· Associate General Counselin

What they invest in

from 9 of 9 portfolio companies

Biotech ×6Healthtech ×2AI & Machine Learning ×1Creator Economy ×1E-commerce ×1EdTech ×1Media & Entertainment ×1Medical Devices ×1

HQs:United States×7Canada×1

Investments · 9 tracked

founders shown can be your intro path

By year:2020 · 12012 · 12 dated

Kyverna Therapeuticskyvernatx.cominNASDAQ: KYTX

Kyverna is a clinical-stage biopharmaceutical company developing CAR T-cell therapies to treat autoimmune diseases through B cell depletion and immune system reset.

BiotechEmeryville, US

Warner Biddle(Chief Executive Officer)inBrian Kotzin(Director)Ian Clark(Director)Ryan Jones(Executive Officer)Karen Walker(Executive Officer)Peter Maag(Executive Officer, Director)in

Co-investorsBain Capital Life SciencesVida VenturesWestlake Village BioPartnersGilead SciencesRTW Investments L.P.Westlake BioPartners

Aminoamino.bio𝕏

Amino Labs produces hands-on biotechnology experiment kits designed to teach genetic engineering and bacterial transformation to beginners in educational and hobbyist settings.

BiotechEdTechSouthern Alberta, CA

Julie Legault(CEO)inJustin Pahara(Biotechnology Expert)

Co-investorsSOSVThe E14 FundAccelAspect VenturesCRV (Charles River Ventures)Highland Capital Partners+1 more

Aminonarvii.com

Narvii.com is an independent information website that publishes articles about digital platforms, online communities, and popular apps.

Creator EconomyMedia & EntertainmentSocial

Alexander Smith(Editor-in-Chief)

Co-investorsBantam GroupHighland Capital PartnersTRANSFORMATION CAPITAL

Fyndfynd.comin𝕏Dec 2020 · $45M

Fynd provides a commerce platform with AI agents for sales and support, letting brands build websites, sell on marketplaces (Amazon, Myntra, Noon, Trendyol), run wholesale operations, modernise retail stores, and manage orders, payments, and logistics.

AI & Machine LearningE-commerceRetail TechSaaSSeattle, US

Farooq Adam(Founder)inNicolas Nezhat(President)

Co-investorsRocketship.vcVelocityTrinity CapitalVenture Catalysts

Inhibrxinhibrx.comin𝕏

Inhibrx develops protein therapeutics, using target biology and protein engineering to create therapeutic candidates in clinical trials for conditions including sarcoma and head and neck cancer.

BiotechLa Jolla, US

Mark Lappe(Executive Officer, Director)inBrendan Eckelman(Director)inDoug Forsyth(Director)Jon Faiz Kayyem(Director)Margery Fischbein(Director)

BoardJudith Li(Director)

Co-investorsLAVLilly Asia VenturesRA Capital

Nevakarnevakar.com

BiotechBridgewater, US

Navneet Puri(Executive Officer)

Co-investorsH.I.G. CapitalH.I.G. HealthBridge Partners

Sierra Oncologysierraoncology.comin𝕏

A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.

BiotechHealthtechMedical DevicesSan Francisco, US

Co-investorsCapital Midwest FundFrazier Life SciencesLongitude CapitalRA CapitalVivo Capital

Tarsa Therapeuticstarsatherapeutics.com

Tarsa Therapeutics developed TBRIA, an oral formulation of calcitonin for treating postmenopausal osteoporosis in women more than five years post menopause when other treatments are unsuitable.

BiotechPhiladelphia, US

David Brand(Executive Officer, Director)inGregory Lumpkin(Executive Officer)

BoardRichard Kollender(Director)Martin Edwards(Director)Eric Bednarski(Director)Derek Ferguson(Director)

Co-investorsForesite CapitalMVM Life Science PartnersQuaker BioVentures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

NeoVista

Exits · 1

1 IPOs

Kyverna TherapeuticsNASDAQ: KYTX

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Oxford Finance LLC made?
Oxford Finance LLC has 9 tracked investments, 1 of which have exited.
What stage does Oxford Finance LLC invest at?
Oxford Finance LLC invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What is Oxford Finance LLC's typical check size?
Oxford Finance LLC typically writes checks of $5M – $125M.
What sectors does Oxford Finance LLC focus on?
Oxford Finance LLC focuses on Biotech, Healthtech, Medical Devices, PropTech.
Where is Oxford Finance LLC located?
Oxford Finance LLC is headquartered in Alexandria, US.

Similar investors

Featured in lists